Moreover, comparing adenomas and HPs/SSAs in MAP patients, APC mutations were only detectable in adenomas, indicating two possible tumor pathways, one leading to adenomas via APC mutations, and the other leading to HPs/SSAs via KRAS activation. This evidence concerns the gene KRAS and Hermansky-Pudlak syndrome.